Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Preferred Stock Liabilities (2024)

Historic Preferred Stock Liabilities for Traws Pharma (TRAW) over the last 3 years, with Q2 2024 value amounting to $111.6 million.

  • Traws Pharma's Preferred Stock Liabilities changed N/A to $111.6 million in Q2 2024 from the same period last year, while for Jun 2024 it was $111.6 million, marking a year-over-year change of. This contributed to the annual value of $201.3 million for FY2012, which is 6776.67% up from last year.
  • According to the latest figures from Q2 2024, Traws Pharma's Preferred Stock Liabilities is $111.6 million.
  • Over the past 5 years, Traws Pharma's Preferred Stock Liabilities peaked at $111.6 million during Q2 2024, and registered a low of $111.6 million during Q2 2024.